Tom's of Maine non-animal anticaries test evidence is "ample," company maintains.
This article was originally published in The Tan Sheet
TOM'S OF MAINE NON-ANIMAL ANTICARIES TEST EVIDENCE "AMPLE" to prove fluoride bioavailability, the company argued in an Aug. 26 letter to FDA drafted by Washington, D.C.-based law firm Buc & Beardsley. Addressing issues raised by FDA in telephone conversations regarding Tom's February petition proposing alternate test methods, the letter asserts that "FDA has ample evidence from which to conclude that the results of Tom's intraoral test provide equivalent assurance of fluoride bioavailability in lieu of animal caries testing."
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC